# Vinorelbine and XR9576 to Treat Cancer

> **NCT00001944** · PHASE1 · COMPLETED · sponsor: **National Cancer Institute (NCI)** · enrollment: 30 (—)

## Conditions studied

- Breast Cancer
- Cancer
- Lung Cancer
- Ovarian Cancer

## Interventions

- **DRUG:** Vinorelbine
- **DRUG:** XR9576

## Key facts

- **NCT ID:** NCT00001944
- **Lead sponsor:** National Cancer Institute (NCI)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-12
- **Primary completion:** —
- **Final completion:** 2001-06
- **Target enrollment:** 30 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001944

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001944, "Vinorelbine and XR9576 to Treat Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00001944. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*